Sign in

Stoke Therapeutics, Inc.

Income Statement - Stoke Therapeutics, Inc. (STOK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.18 0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.18 0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.21 0.14 0.12 0.12 0.09 0.05 0.04 0.01 0.01
Operating income -0.02 -0.10 -0.11 -0.10 -0.09 -0.05 -0.04 -0.01 -0.01
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.01 -0.09 -0.10 -0.10 -0.09 -0.05 -0.03 -0.01 -0.01
Income tax expense -0.09 0.00 -0.01 0.00 0.00 0.00 0.00 0.00
Net income -0.01 -0.09 -0.10 -0.09 -0.08 -0.05 -0.03 -0.01 -0.01
Show Quarterly Income Statement

Income Statement - Stoke Therapeutics, Inc. (STOK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.01 0.00 0.01 0.01 0.16 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.01 0.00 0.01 0.01 0.16 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.06 0.05 0.04 0.05 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Operating income -0.05 -0.06 -0.04 -0.03 0.11 -0.01 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.06 -0.04 -0.02 0.11 -0.01 -0.03 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.05 -0.06 -0.04 -0.02 0.11 -0.01 -0.03 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
4 days ago

Balance Sheet - Stoke Therapeutics, Inc. (STOK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 0.28 0.22 0.20 0.23 0.22 0.29 0.22 0.11 0.00
Accounts receivable, net 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.01 -0.07 0.00 0.00
Other current assets 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total current assets 0.31 0.23 0.22 0.24 0.23 0.29 0.23 0.11 0.00
Total non-current assets + 0.11 0.04 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total assets 0.42 0.27 0.23 0.26 0.24 0.30 0.23 0.11 0.00
Total current liabilities + 0.06 0.04 0.03 0.03 0.02 0.01 0.00 0.00 0.00
Total non-current liabilities + 0.01 0.00 0.04 0.04 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.07 0.04 0.07 0.07 0.02 0.01 0.00 0.00 0.00
Total stockholders' equity + 0.35 0.23 0.16 0.18 0.22 0.29 0.22 0.11 0.00
Common shares outstanding 59 54 44 39 37 33 18 24 24
Show Quarterly Balance Sheet

Balance Sheet - Stoke Therapeutics, Inc. (STOK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 0.34 0.28 0.25 0.25 0.36 0.22 0.24 0.28 0.18 0.20 0.21 0.23 0.25 0.23 0.25 0.28 0.29 0.22 0.24 0.25 0.27 0.29 0.19 0.20 0.21 0.22 0.23 0.24 0.10 0.11 0.00 0.00 0.00
Accounts receivable, net 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Other current assets 0.02 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Total current assets 0.37 0.31 0.27 0.27 0.38 0.23 0.25 0.30 0.19 0.22 0.23 0.25 0.27 0.24 0.26 0.29 0.31 0.23 0.24 0.26 0.28 0.29 0.20 0.21 0.22 0.23 0.24 0.24 0.10 0.11 0.00
Total non-current assets + 0.08 0.11 0.09 0.11 0.03 0.04 0.04 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.44 0.42 0.36 0.38 0.41 0.27 0.29 0.31 0.21 0.23 0.24 0.26 0.28 0.26 0.28 0.30 0.32 0.24 0.25 0.26 0.28 0.30 0.20 0.21 0.22 0.23 0.24 0.25 0.10 0.11 0.00
Total current liabilities + 0.04 0.06 0.04 0.04 0.04 0.04 0.05 0.04 0.04 0.03 0.03 0.02 0.03 0.03 0.03 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.02 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.05 0.07 0.05 0.05 0.06 0.04 0.06 0.07 0.06 0.07 0.07 0.07 0.07 0.07 0.07 0.08 0.08 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.39 0.35 0.31 0.33 0.35 0.23 0.23 0.24 0.14 0.16 0.17 0.19 0.21 0.18 0.20 0.22 0.24 0.22 0.24 0.26 0.27 0.29 0.19 0.20 0.21 0.22 0.23 0.24 0.10 0.11 0.00
Common shares outstanding 63 58 59 58 59 57 56 56 46 45 44 44 43 39 39 39 37 37 37 37 37 35 33 33 33 25 33 31 30 24 24 24 24
4 days ago

Cash Flow - Stoke Therapeutics, Inc. (STOK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + 0.05 -0.09 -0.08 -0.03 -0.07 -0.04 -0.03 -0.01 -0.01
Cash flow from investing + -0.19 -0.11 0.11 -0.05 -0.08 0.00 0.00 0.00 0.00
Cash flow from financing + 0.10 0.13 0.05 0.05 0.00 0.11 0.15 0.12 0.01
Change in cash -0.04 -0.06 0.08 -0.03 -0.14 0.06 0.12 0.10 0.00
Show Quarterly Cash Flow

Cash Flow - Stoke Therapeutics, Inc. (STOK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + -0.06 -0.03 -0.03 -0.03 0.13 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 0.03 -0.02 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00
Cash flow from investing + 0.05 -0.06 0.01 -0.15 0.01 0.00 -0.03 -0.09 0.01 0.01 0.01 0.02 0.05 0.02 0.07 0.00 -0.14 0.01 -0.01 -0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.08 0.09 0.00 0.00 0.00 0.00 0.01 0.12 0.00 0.01 0.00 0.00 0.05 0.00 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.00 0.15 0.00 0.09 0.01 0.00 0.01
Change in cash 0.07 0.00 -0.02 -0.17 0.15 -0.02 -0.04 0.01 -0.01 0.00 0.00 0.00 0.08 0.00 0.05 -0.02 -0.06 0.00 -0.02 -0.10 -0.02 0.10 -0.01 -0.01 -0.01 -0.01 -0.01 0.14 -0.01 0.09 0.01 0.00 0.01
4 days ago

Stoke Therapeutics, Inc. (STOK) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Dividend Payout

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Change In Inventory

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Net Income

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Stoke Therapeutics, Inc. (STOK) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago